Revvity | PKI - 税前利润



金融业
股票价格
USD
资产
USD 12.05B
现金及等价物
USD 860.32M
销售成本
USD 312.82M
流动资产
USD 2.3B
流动负债
USD 1.28B
债务
USD 3.35B
股息收益率
0.25
EBIT
USD 126.14M
EBITDA
USD 228.18M
员工
11K
EPS每股收益
USD 1.41
股本和储备
USD 7.18B
销售毛利
USD 387.66M
债务利息支出
USD 24.72M
利息收入
USD 6.3M
贷款资金
USD 2.63B
市值
USD 13.74B
净收入
USD 51.82M
营业费用
USD 603.55M
营业利润
USD 126.14M
普通股股本
USD 111.63M
PE价格收益
36.47
税前利润
USD 187.24M
销售收入
USD 729.68M
销售和管理费用
USD 278.58M
股票
USD 378.5M
贸易债权人
USD 165.74M
应收帐款人
USD 709.18M


税前利润 更改 日
Agilent USD 364M 78M 2025-12
Align Technology USD 148.69M 193K 2026-06
Bio Techne USD 50.78M 34.21M 2025-12
Bio-Rad Laboratories USD -689.8M 1.62B 2026-03
Bruker USD 117M 95.1M 2026-06
Celltrion KRW 11.84B 1.34B 2026-03
Charles River Laboratories USD -294.1M 464.13M 2025-12
Cspc Pharmaceutical CNY 505.59M 706M 2025-12
Danaher USD 1.08B 157M 2026-06
Dentsply International USD -42M 105M 2026-03
Dianthus Therapeutics USD -40.83M 23.6M 2026-03
Divis Laboratories Ltd INR 11.8B 2.17B 2026-06
Edwards Lifesciences USD 529.3M 90.4M 2026-06
Illumina USD 260M 103M 2026-06
Intuitive Surgical USD 940.4M 15.2M 2026-03
IQVIA Holdings USD 301M 5.92B 2026-06
Kangmei Pharma CNY -14.01M 16.08M 2026-03
Knight Therapeutics CAD -1.92M 13.69M 2025-09
Laboratorios Farma EUR 26.78M 94.77M 2025-06
Laboratory Of America USD 8.73B 8.54B 2026-03
Medical Developments International AUD -149K 466K 2025-06
Mesa Laboratories USD -2.22M 6.03M 2024-12
Mettler Toledo International USD 209.66M 119.42M 2026-03
Myriad Genetics USD 4.6M 3.4M 2025-12
Neuren Pharmaceuticals AUD 19.21M 9.35M 2025-12
OraSure Technologies USD -18.43M 5.14M 2025-12
Organigram Holdings CAD -921K 40.8M 2026-03
Pacific Biosciences Of California USD -40.17M 2.55M 2025-12
Pharma Mar EUR -993K 2.59M 2026-06
Qiagen NV USD 85.83M 23.34M 2026-03
Quest Diagnostics USD 334M 4M 2026-03
Quidel USD -79.5M 32.9M 2026-03
Repligen USD 14.15M 12.38M 2026-06
Revvity USD 187.24M 137.25M 2026-06
Sartorius EUR 127M 30.8M 2026-06
Thermo Fisher Scientific USD 1.73B 389M 2026-03
Tilray USD -39.96M 39.19M 2025-09
Waters USD -88M 352.18M 2026-03
Zealand Pharma A/S -394M 12.5M 2026-03
Zz Pientze Pharmaceu CNY 876.07M 352.96M 2026-03